ID   B4GA1_HUMAN             Reviewed;         415 AA.
AC   O43505; Q4TTN0;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   10-MAY-2017, entry version 133.
DE   RecName: Full=Beta-1,4-glucuronyltransferase 1 {ECO:0000303|PubMed:25279697, ECO:0000303|PubMed:25279699, ECO:0000312|HGNC:HGNC:15685};
DE            EC=2.4.1.- {ECO:0000269|PubMed:25279697, ECO:0000269|PubMed:25279699};
DE   AltName: Full=I-beta-1,3-N-acetylglucosaminyltransferase;
DE            Short=iGnT;
DE   AltName: Full=N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase;
DE   AltName: Full=Poly-N-acetyllactosamine extension enzyme;
DE   AltName: Full=UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1;
GN   Name=B4GAT1 {ECO:0000303|PubMed:25279697, ECO:0000303|PubMed:25279699,
GN   ECO:0000312|HGNC:HGNC:15685};
GN   Synonyms=B3GNT1 {ECO:0000312|HGNC:HGNC:15685}, B3GNT6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=9405606; DOI=10.1073/pnas.94.26.14294;
RA   Sasaki K., Kurata-Miura K., Ujita M., Angata K., Nakagawa S.,
RA   Sekine S., Nishi T., Fukuda M.;
RT   "Expression cloning of cDNA encoding a human beta-1,3-N-
RT   acetylglucosaminyltransferase that is essential for poly-N-
RT   acetyllactosamine synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14294-14299(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-253.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH LARGE1 AND
RP   LARGE2.
RX   PubMed=19587235; DOI=10.1073/pnas.0904515106;
RA   Bao X., Kobayashi M., Hatakeyama S., Angata K., Gullberg D.,
RA   Nakayama J., Fukuda M.N., Fukuda M.;
RT   "Tumor suppressor function of laminin-binding alpha-dystroglycan
RT   requires a distinct beta3-N-acetylglucosaminyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12109-12114(2009).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND VARIANTS MDDGA13 ASP-390 AND
RP   VAL-406.
RX   PubMed=23359570; DOI=10.1093/hmg/ddt021;
RA   Buysse K., Riemersma M., Powell G., van Reeuwijk J., Chitayat D.,
RA   Roscioli T., Kamsteeg E.J., van den Elzen C., van Beusekom E.,
RA   Blaser S., Babul-Hirji R., Halliday W., Wright G.J., Stemple D.L.,
RA   Lin Y.Y., Lefeber D.J., van Bokhoven H.;
RT   "Missense mutations in beta-1,3-N-acetylglucosaminyltransferase 1
RT   (B3GNT1) cause Walker-Warburg syndrome.";
RL   Hum. Mol. Genet. 22:1746-1754(2013).
RN   [6]
RP   INVOLVEMENT IN MDDGA13.
RX   PubMed=23877401; DOI=10.1007/s10048-013-0367-8;
RA   Shaheen R., Faqeih E., Ansari S., Alkuraya F.S.;
RT   "A truncating mutation in B3GNT1 causes severe Walker-Warburg
RT   syndrome.";
RL   Neurogenetics 14:243-245(2013).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PATHWAY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF MET-155 AND
RP   227-ASP--ASP-229.
RX   PubMed=25279699; DOI=10.7554/eLife.03941;
RA   Willer T., Inamori K.I., Venzke D., Harvey C., Morgensen G., Hara Y.,
RA   Beltran Valero de Bernabe D., Yu L., Wright K.M., Campbell K.P.;
RT   "The glucuronyltransferase B4GAT1 is required for initiation of LARGE-
RT   mediated alpha-dystroglycan functional glycosylation.";
RL   Elife 3:0-0(2014).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=25279697; DOI=10.7554/eLife.03943;
RA   Praissman J.L., Live D.H., Wang S., Ramiah A., Chinoy Z.S.,
RA   Boons G.J., Moremen K.W., Wells L.;
RT   "B4GAT1 is the priming enzyme for the LARGE-dependent functional
RT   glycosylation of alpha-dystroglycan.";
RL   Elife 3:0-0(2014).
CC   -!- FUNCTION: Beta-1,4-glucuronyltransferase involved in O-
CC       mannosylation of alpha-dystroglycan (DAG1). Transfers a glucuronic
CC       acid (GlcA) residue onto a xylose (Xyl) acceptor to produce the
CC       glucuronyl-beta-1,4-xylose-beta disaccharide primer, which is
CC       further elongated by LARGE1, during synthesis of phosphorylated O-
CC       mannosyl glycan (PubMed:25279699, PubMed:25279697). Phosphorylated
CC       O-mannosyl glycan is a carbohydrate is a carbohydrate structure
CC       present in alpha-dystroglycan (DAG1), which is required for
CC       binding laminin G-like domain-containing extracellular proteins
CC       with high affinity (PubMed:25279699, PubMed:25279697). Required
CC       for axon guidance; via its function in O-mannosylation of alpha-
CC       dystroglycan (DAG1) (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BWP8, ECO:0000269|PubMed:19587235,
CC       ECO:0000269|PubMed:23359570, ECO:0000269|PubMed:25279697,
CC       ECO:0000269|PubMed:25279699}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:25279699};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 7.0. {ECO:0000269|PubMed:25279699};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:25279697, ECO:0000269|PubMed:25279699,
CC       ECO:0000269|PubMed:9405606}.
CC   -!- SUBUNIT: Interacts with LARGE1 and LARGE2.
CC       {ECO:0000269|PubMed:19587235}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:19587235, ECO:0000269|PubMed:23359570,
CC       ECO:0000269|PubMed:25279699}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:23359570}. Note=Localizes near the trans-Golgi
CC       apparatus. {ECO:0000269|PubMed:25279699}.
CC   -!- TISSUE SPECIFICITY: In the adult, highly expressed in heart,
CC       brain, skeletal muscle and kidney and to a lesser extent in
CC       placenta, pancreas, spleen, prostate, testis, ovary, small
CC       intestine and colon. Very weak expression in lung, liver, thymus
CC       and peripheral blood leukocytes. In fetal highly expressed in
CC       brain and kidney and to a lesser extent in lung and liver.
CC       {ECO:0000269|PubMed:9405606}.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with
CC       brain and eye anomalies A13 (MDDGA13) [MIM:615287]: An autosomal
CC       recessive disorder characterized by congenital muscular dystrophy
CC       associated with cobblestone lissencephaly and other brain
CC       anomalies, eye malformations, profound mental retardation, and
CC       death usually in the first years of life. Included diseases are
CC       the more severe Walker-Warburg syndrome and the slightly less
CC       severe muscle-eye-brain disease. {ECO:0000269|PubMed:23359570,
CC       ECO:0000269|PubMed:23877401}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 49 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was initially characterized as a beta-1,3-N-
CC       acetylglucosaminyltransferase involved in the synthesis of poly-N-
CC       acetyllactosamine, able to initiate the synthesis or the
CC       elongation of the linear poly-N-acetyllactosaminoglycans
CC       (PubMed:9405606). However, it was later shown that it acts as a
CC       beta-1,4-glucuronyltransferase (PubMed:25279699, PubMed:25279697).
CC       {ECO:0000269|PubMed:25279697, ECO:0000269|PubMed:25279699,
CC       ECO:0000305|PubMed:9405606}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/b3gnt6/";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=N-
CC       acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_547";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF029893; AAC39538.1; -; mRNA.
DR   EMBL; DQ066422; AAY46155.1; -; Genomic_DNA.
DR   EMBL; BC021965; AAH21965.1; -; mRNA.
DR   CCDS; CCDS8136.1; -.
DR   RefSeq; NP_006867.1; NM_006876.2.
DR   UniGene; Hs.8526; -.
DR   ProteinModelPortal; O43505; -.
DR   BioGrid; 116229; 45.
DR   DIP; DIP-48921N; -.
DR   IntAct; O43505; 3.
DR   STRING; 9606.ENSP00000309096; -.
DR   CAZy; GT49; Glycosyltransferase Family 49.
DR   iPTMnet; O43505; -.
DR   PhosphoSitePlus; O43505; -.
DR   SwissPalm; O43505; -.
DR   BioMuta; B3GNT1; -.
DR   EPD; O43505; -.
DR   MaxQB; O43505; -.
DR   PaxDb; O43505; -.
DR   PeptideAtlas; O43505; -.
DR   PRIDE; O43505; -.
DR   DNASU; 11041; -.
DR   Ensembl; ENST00000311181; ENSP00000309096; ENSG00000174684.
DR   GeneID; 11041; -.
DR   KEGG; hsa:11041; -.
DR   UCSC; uc001ohr.4; human.
DR   CTD; 11041; -.
DR   DisGeNET; 11041; -.
DR   GeneCards; B4GAT1; -.
DR   HGNC; HGNC:15685; B4GAT1.
DR   HPA; HPA015484; -.
DR   MalaCards; B4GAT1; -.
DR   MIM; 605517; gene.
DR   MIM; 615287; phenotype.
DR   neXtProt; NX_O43505; -.
DR   OpenTargets; ENSG00000174684; -.
DR   Orphanet; 899; Walker-Warburg syndrome.
DR   PharmGKB; PA164741279; -.
DR   eggNOG; KOG3765; Eukaryota.
DR   eggNOG; ENOG410XRNY; LUCA.
DR   GeneTree; ENSGT00530000063165; -.
DR   HOGENOM; HOG000064521; -.
DR   HOVERGEN; HBG080885; -.
DR   InParanoid; O43505; -.
DR   KO; K21032; -.
DR   OMA; MPMSKTE; -.
DR   OrthoDB; EOG091G0K0J; -.
DR   PhylomeDB; O43505; -.
DR   TreeFam; TF319168; -.
DR   BioCyc; MetaCyc:HS10821-MONOMER; -.
DR   BRENDA; 2.4.1.149; 2681.
DR   Reactome; R-HSA-2022854; Keratan sulfate biosynthesis.
DR   Reactome; R-HSA-5173105; O-linked glycosylation.
DR   UniPathway; UPA00378; -.
DR   GeneWiki; B3GNT1; -.
DR   GenomeRNAi; 11041; -.
DR   PRO; PR:O43505; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000174684; -.
DR   CleanEx; HS_B3GNT1; -.
DR   CleanEx; HS_B3GNT6; -.
DR   ExpressionAtlas; O43505; baseline and differential.
DR   Genevisible; O43505; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0030173; C:integral component of Golgi membrane; NAS:UniProtKB.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008532; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome.
DR   GO; GO:0030311; P:poly-N-acetyllactosamine biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; TAS:Reactome.
DR   GO; GO:0035269; P:protein O-linked mannosylation; IDA:UniProtKB.
PE   1: Evidence at protein level;
KW   Complete proteome; Congenital muscular dystrophy; Disease mutation;
KW   Dystroglycanopathy; Glycoprotein; Glycosyltransferase;
KW   Golgi apparatus; Lissencephaly; Manganese; Membrane; Metal-binding;
KW   Polymorphism; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    415       Beta-1,4-glucuronyltransferase 1.
FT                                /FTId=PRO_0000080555.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     36       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     37    415       Lumenal. {ECO:0000255}.
FT   METAL       227    227       Manganese. {ECO:0000305|PubMed:25279699}.
FT   METAL       229    229       Manganese. {ECO:0000305|PubMed:25279699}.
FT   CARBOHYD    204    204       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    300    300       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     253    253       T -> S (in dbSNP:rs35429253).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_025019.
FT   VARIANT     390    390       N -> D (in MDDGA13; dbSNP:rs397509397).
FT                                {ECO:0000269|PubMed:23359570}.
FT                                /FTId=VAR_069989.
FT   VARIANT     406    406       A -> V (in MDDGA13; dbSNP:rs397509396).
FT                                {ECO:0000269|PubMed:23359570}.
FT                                /FTId=VAR_069990.
FT   MUTAGEN     155    155       M->T: In Mut3; mislocalization to the
FT                                endoplasmic reticulum.
FT                                {ECO:0000269|PubMed:25279699}.
FT   MUTAGEN     227    229       DVD->NVN: In Mut2; mislocalization to the
FT                                endoplasmic reticulum.
FT                                {ECO:0000269|PubMed:25279699}.
SQ   SEQUENCE   415 AA;  47119 MW;  432D00980EFE2B35 CRC64;
     MQMSYAIRCA FYQLLLAALM LVAMLQLLYL SLLSGLHGQE EQDQYFEFFP PSPRSVDQVK
     AQLRTALASG GVLDASGDYR VYRGLLKTTM DPNDVILATH ASVDNLLHLS GLLERWEGPL
     SVSVFAATKE EAQLATVLAY ALSSHCPDMR ARVAMHLVCP SRYEAAVPDP REPGEFALLR
     SCQEVFDKLA RVAQPGINYA LGTNVSYPNN LLRNLAREGA NYALVIDVDM VPSEGLWRGL
     REMLDQSNQW GGTALVVPAF EIRRARRMPM NKNELVQLYQ VGEVRPFYYG LCTPCQAPTN
     YSRWVNLPEE SLLRPAYVVP WQDPWEPFYV AGGKVPTFDE RFRQYGFNRI SQACELHVAG
     FDFEVLNEGF LVHKGFKEAL KFHPQKEAEN QHNKILYRQF KQELKAKYPN SPRRC
//
